EPA 2026

Meet SEBERS Medical at the EPA Congress 2026

Join SEBERS Medical at the European Psychiatry Association (EPA) Congress 2026 and discover how modern Transcranial Magnetic Stimulation (TMS) is transforming the treatment of Major Depressive Disorder (MDD) and other neuropsychiatric conditions.

At our booth, we will showcase the Blossom TMS™ Therapy System—our FDA-cleared and CE-marked TMS solution designed to make daily clinical practice simpler, more efficient, and more comfortable for both clinicians and patients. With intuitive workflow guidance, integrated motor threshold assistance, high-performance liquid coil cooling, and pre-installed treatment protocols, Blossom TMS supports reliable and reproducible TMS therapy from the very first session.

Experience the TMS Pilot™, our innovative coil-mounted positioning system that enables clinicians to visualize the stimulation target directly beneath the coil. By simplifying coil positioning and ensuring fast, accurate, and reproducible placement throughout the treatment course, the TMS Pilot helps improve workflow efficiency and treatment consistency.

Whether you are planning to establish a new TMS clinic, expand your neuromodulation services, or optimize existing treatment workflows, our team will be available to demonstrate how the Blossom TMS™ Therapy System can support your clinical practice.

Visit SEBERS Medical at the EPA Congress 2026 and discover how we are making TMS therapy more intuitive, more efficient, and more accessible for mental health professionals across Europe.

SEBERS Medical – We make TMS easy.